Press Release – January 21, 2016
Schulman IRB Chair Joins Provision Research Compliance Services as Executive Director, Consulting and Compliance Services
CINCINNATI, Jan. 21, 2016 /PRNewswire/ -- Provision Research Compliance Services, the industry's leading provider for global good clinical practice (GCP) and human research protection (HRP) compliance services, is pleased to announce Sharon Nelson, MSN, CNS, RN, CIP, has joined the organization as Executive Director of Consulting and Compliance Services.
In her new role, Ms. Nelson will assist Provision's clients in developing and expanding HRP programs to increase efficiencies, promote organizational growth and improve the overall quality of protection and oversight for humans participating in clinical research.
"Sharon's expertise provides substantial skill and perspective to the Provision team," said Michael Woods, General Manager at Provision. "With Sharon's help, Provision's clients will be able to establish effective, robust human subject protection programs and grow successful research programs."
Ms. Nelson has over 14 years of experience in IRB leadership and board operations. She previously served as Board Chair at Schulman IRB where she was responsible for the leadership and oversight of all aspects of IRB operations. She has extensive experience in process development and implementation, staff development, and board education and growth. Ms. Nelson is a clinical nurse specialist and holds a Master of Science in Nursing degree.
About Provision Research Compliance Services
Provision Research Compliance Services is a joint venture between Falcon Consulting Group and Schulman IRB, combining the organizations' the extensive good clinical practice (GCP) quality assurance and human research protection (HRP) expertise to provide the research services industry with the first global compliance organization of its kind. Provision offers global consultancy services for the development and implementation of GCP and HRP procedural standards and programs for the conduct of clinical research studies. For more information, visit www.provisionrcs.com.